Drew Gill Wins MLF Bass Pro Tour B&W Trailer Hitches Stage 1 on Lake Guntersville Presented by Mercury Illinois pro catches 28 bass weighing 82 pounds, 4 ounces and holds off hard charge from Walker and Wheeler to win season-opening event and earn top prize of $125,000 GlobeNewswire January 19, 2026 GUNTERSVILLE, Ala., Jan. 18, […]
D3 Bio, a global clinical?stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications: — D3S?003 — a KRAS G12D inhibitor — enabling the start of a Phase 1 first?in?human clinical trial. — A Phase 2 combination trial
SINGAPORE, Jan. 18, 2026 (GLOBE NEWSWIRE) — Singapore-based OPay, a leading digital banking platform in emerging markets, has announced key management appointments as part of its new global strategic direction. The appointments took effect on December 1, 2025. The newly formed management team includes James Zhou as Executive Chairman, Lars Boilesen as Co-CEO, Stephen as
SINGAPORE, Jan. 18, 2026 (GLOBE NEWSWIRE) — OPay, a leader in emerging market digital banking headquartered in Singapore, has appointed Lars Boilesen as Co-CEO, effective December 1, 2025. As Co-CEO, Lars will be responsible for regulatory communication, business implementation, and strategic expansion in target markets, reporting to the OPay Board of Directors. Lars Boilesen brings
OPay Forms Global Core Management Team, Appoints Four Executives to Lead New Strategic Chapter GlobeNewswire January 19, 2026 SINGAPORE, Jan. 18, 2026 (GLOBE NEWSWIRE) — Singapore-based OPay, a leading digital banking platform in emerging markets, has announced key management appointments as part of its new global strategic direction. The appointments took effect on December 1,
OPay Appoints Tech Industry Leader Lars Boilesen as Co-CEO GlobeNewswire January 19, 2026 SINGAPORE, Jan. 18, 2026 (GLOBE NEWSWIRE) — OPay, a leader in emerging market digital banking headquartered in Singapore, has appointed Lars Boilesen as Co-CEO, effective December 1, 2025. As Co-CEO, Lars will be responsible for regulatory communication, business implementation, and strategic expansion
AbelZeta Pharma, Inc. (“AbelZeta”), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, announced that AstraZeneca has agreed to acquire AbelZeta’s 50% share of the China development and commercialization rights to C-CAR031, such that AstraZeneca acquires the sole right to develop, manufacture and commercialize C-CAR031 globally.
(NYSE:FCN), HONG KONG, Jan. 18, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Speed Liu as a Senior Managing Director in the Business Transformation practice in Asia within the firm's Corporate Finance & Restructuring segment. Mr. Liu, who is based in Hong Kong, joins FTI Consulting with more than
Private Equity Expert Speed Liu Joins FTI Consulting in Hong Kong GlobeNewswire January 19, 2026 HONG KONG, Jan. 18, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Speed Liu as a Senior Managing Director in the Business Transformation practice in Asia within the firm's Corporate Finance & Restructuring segment.
Materials research generates vast amounts of data, but the information often exists in manufacturer-specific formats and the terminology is inconsistent, making it difficult to aggregate, compare, and reuse. Traditionally, researchers have had to spend considerable time on tedious tasks, such as format conversion, metadata assignment, and characteristics extraction. These extra steps can make researchers reluctant